The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression

被引:0
|
作者
Paxton, WA [1 ]
Kang, S [1 ]
Koup, RA [1 ]
机构
[1] Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The purified CD4(+) lymphocytes of a group of highly exposed but HIV-1-uninfected individuals mere determined to be less susceptible to infection with multiple non-syncytium-inducing (NSI) primary isolates of HIV-1 than were CD4(+) lymphocytes from nonexposed control individuals. This relative resistance to HIV-1 infection did not extend to T cell line-adapted or syncytium-inducing (SI) primary viral isolates, mas restricted by the envelope glycoprotein, and was associated with an increased production of the C-C chemokines RANTES, MIP-1 alpha, and MIP-1 beta, The block to replication in CD4(+) lymphocytes from two exposed-uninfected subjects was at the point of entry, as was the block imposed by the recombinant C-C chemokines RANTES, MIP-1 alpha, and MIP-1 beta, Resistance to infection and the high production of beta chemokines were characteristic of every CD4(+) lymphocyte clone from the exposed-uninfected subjects. We have now identified the mechanism underlying this in vitro and in vivo resistance to infection: These individuals have inherited a homozygous 32-bp nucleotide deletion (Delta 32) within the gene encoding the coreceptor for primary NSI isolates of HIV-1 (CCR5), This deletion encodes a severely truncated and unstable protein that is not expressed on the cell surface. This allele is common in the Caucasian population, with a frequency of 0.0808, but is not found in people of African or Asian ancestry. To determine its role in HIV-1 transmission and disease progression, me analyzed the CCR5 genotype of 1252 homosexual men enrolled in the Chicago component of the Multicenter AIDS Cohort Study (MACS), No infected participant was found to be homozygous for the Delta 32 allele whereas 3.6% of at-risk but uninfected Caucasian participants were homozygous, showing the highly protective role of this genotype against sexual acquisition of HIV-1, No evidence was found to suggest that heterozygotes mere protected against HIV-1 infection, but a limited protective role against disease progression was noted. The Delta 32 allele of CCR5 is therefore an important host factor in HIV-1 transmission and pathogenesis.
引用
收藏
页码:S89 / S92
页数:4
相关论文
共 50 条
  • [21] Genetic polymorphism of CCR5 gene and HIV disease:: the heterozygous (CCR5/Δccr5) genotype is neither essential nor sufficient for protection against disease progression
    Morawetz, RA
    Rizzardi, GP
    Glauser, D
    Rutschmann, O
    Hirschel, B
    Perrin, L
    Opravil, M
    Flepp, M
    von Overbeck, J
    Glauser, MP
    Ghezzi, S
    Vicenzi, E
    Poli, G
    Lazzarin, A
    Pantaleo, G
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) : 3223 - 3227
  • [22] HIV-1 coreceptor usage, transmission, and disease progression
    Philpott, SM
    CURRENT HIV RESEARCH, 2003, 1 (02) : 217 - 227
  • [23] Interactions of CCR5, the Main HIV Coreceptor, with Rantes and Other Ligands
    Morin, Sebastien
    Nisius, Lydia
    Wiktor, Maciej
    Kebbel, Fabian
    Stahlberg, Henning
    Sass, Hans Juergen
    Grzesiek, Stephan
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 239A - 240A
  • [24] CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children
    Misrahi, M
    Teglas, JP
    N'Go, N
    Burgard, M
    Mayaux, MJ
    Rouzioux, C
    Delfraissy, JF
    Blanche, S
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (04): : 277 - 280
  • [25] Polymorphism of CCR5 affecting HIV disease progression in the Japanese population
    Kageyama, S
    Mimaya, JI
    Yamada, K
    Kurimura, T
    Shiraki, K
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (11) : 991 - 995
  • [26] CCR5 genotypes and progression to HIV disease in perinatally infected children
    Araujo de Angelis, Daniela Souza
    Freire, Wilton Santos
    Pannuti, Claudio Sergio
    de Menezes Succi, Regina Cella
    Machado, Daisy Maria
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (02): : 196 - 198
  • [27] Biology of CCR5 and its role in HIV infection and treatment
    Lederman, Michael M.
    Penn-Nicholson, Adam
    Cho, Michael
    Mosier, Donald
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (07): : 815 - 826
  • [28] HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: Independence from G protein signaling and importance of coreceptor downmodulation
    Alkhatib, G
    Locati, M
    Kennedy, PE
    Murphy, PM
    Berger, EA
    VIROLOGY, 1997, 234 (02) : 340 - 348
  • [29] The coreceptor mutation CCR5Δ32 influences the dynamics of HIV epidemics and is selected for by HIV
    Sullivan, AD
    Wigginton, J
    Kirschner, D
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) : 10214 - 10219
  • [30] CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120
    Wang, WK
    Dudek, T
    Zhao, YJ
    Brumblay, HG
    Essex, M
    Lee, TH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (10) : 5740 - 5745